High Nuchal Translucency

What is being measured, and why at that exact moment

Nuchal translucency — often shortened to NT, and sometimes described to you simply as the fluid or the measurement at the back of the baby's neck — is defined by the NHS Fetal Anomaly Screening Programme handbook as "the ultrasound appearance of a collection of fluid under the skin at the back of the baby's neck. The thickness of the NT is measured and used as part of the combined test to calculate the chance of having a baby with T21, T18 or T13."

All babies have some fluid there. The measurement is only interpretable in a narrow window, which is why the combined test has a strict eligibility rule: the handbook states that it "can only be performed when the CRL measurement is between 45.0mm and 84.0mm", using the crown rump length rather than weeks and days. If the CRL is under 45.0mm you are recalled for another scan; above 84.0mm the window has closed and the quadruple blood test is offered later instead.

One rule is easy to miss and matters enormously: "The NT measurement must be used in combination with a maternal blood sample for calculating the chance result. It must not be used alone." A measurement without the blood test is not a screening result.

The 3.5mm threshold, and what it actually triggers

The handbook is specific: "An NT measurement equal to or greater than 3.5mm may be associated with T21, T18 and T13 and serious cardiac conditions."

What follows is unusual in NHS screening, because it does not wait for the blood results. "For a woman who accepts the offer of the combined test, an NT measurement equal to or greater than 3.5mm is usually associated with a higher chance result. In these cases, the blood sample must be taken, processed and the chance result calculated in the usual way. Referral, in line with local guidelines, must be made straight away and not delayed until the chance results are known."

So if you were referred on the day of the scan, before any numbers came back, that is the pathway working exactly as written rather than a sign that something worse has been found.

If you declined the combined test and an increased NT was seen anyway, the handbook says "local guidelines should be in place for the clinical management of NT measurements equal to or greater than 3.5mm and any unexpected findings on the ultrasound scan" — the national programme hands that to your unit.

The sentence to hold onto

The handbook ends its NT section with it: "It is important to note a baby with an increased NT may not have any of these conditions."

An increased nuchal translucency is a marker, not a diagnosis. Many babies with a measurement above 3.5mm have normal chromosomes and a normal heart. The measurement identifies a group who need looking at more closely, and it is entirely possible to be in that group and have nothing found.

Why the heart, and not just the chromosomes

The cardiac association in that quoted sentence is the part most parents are not expecting, and it is the reason your follow-up may include a specialist heart scan even after chromosome testing comes back normal. Increased nuchal fluid is associated with structural heart conditions independently of trisomy.

In practice this usually means a fetal echocardiogram, generally in the second trimester, in addition to the routine 20-week screening scan. The 20-week scan already checks the baby's heart as part of the 11 conditions the NHS programme screens for, but a dedicated cardiac scan looks in more detail.

The testing choices in front of you

Following a higher-chance result from the combined test, the FASP handbook sets out three options: "no further testing", "NIPT screening for all 3 conditions", or "prenatal diagnosis (PND), such as chorionic villus sampling (CVS) or amniocentesis".

With a substantially increased NT, teams often discuss going straight to a diagnostic test rather than through NIPT, because NIPT looks only at trisomies 21, 18 and 13 while an invasive sample can be analysed more broadly. That is a discussion to have explicitly: ask what would be tested for on the sample, and whether microarray testing is included.

The programme sets timing standards for this. Following higher-chance combined or quadruple results, "the PND procedure should be made available to women within 3 working days or fewer". You should not be waiting weeks.

What increased NT does not tell you

It does not tell you the severity of anything. It does not distinguish between a condition and a transient finding that resolves. And a measurement just under 3.5mm is not a separate diagnosis — under the NHS programme, an NT below that threshold simply feeds into the chance calculation with the blood markers and your age, and most such pregnancies return a lower-chance result.

Measurements are also reported precisely rather than rounded. The handbook requires the CRL to be reported "as measured and not rounded to a whole number" and NT to be recorded "accurately even if it is less than 1.0mm". If your reported figure looks oddly specific, that is the standard.

Getting through the wait

The interval between an increased NT and a definitive answer is genuinely hard, and it is usually days rather than weeks. Ask your team three concrete questions: exactly what measurement was recorded, whether the combined test chance result has come back and what it is, and which specialist you have been referred to and when.

Antenatal Results and Choices is the UK charity that supports parents through screening results and decisions, and midwives will often refer to it by name. Independent support is worth taking up early rather than after a decision has been made.